6:20 pm
7:20 pm
Room 12
Sponsored symposia: Menarini
Savefor later Page saved! You can go back to this later in your Diabetes and Me Close

Are SGLT2i the new ‘statins’: The shifting paradigm of risk-based prevention: Join the debate!

This is a promotional symposia sponsored and organised by A. Menarini Farmaceutica Internazionale SRL and is for UK healthcare professionals only. Prescribing information and adverse event reporting will be available at the symposium.

Chair: Naresh Kanumilli, Greater Manchester

Speakers: Rahul Mohan, Nottingham

Waqas Tahir, Bradford

This house believes that SGLT2 inhibitors are the new statins Our speakers forward their motions and compelling arguments for debate. You will have a chance to challenge our speakers and evaluate the evidence presented and vote!

PP-ENDO-UK-0332 | March 2024

Please note that this session is not eligible for accreditation.  

Savefor later Page saved! You can go back to this later in your Diabetes and Me Close

Share this Page

FacebookWhatsappTwitterPinterestEmailPrint
Back to Top
Brand Icons/Telephonecheck - FontAwesome““icons/tickicons/uk